FindTrial
Sign In

Evaluation of efficacy of bicalutamide mesotherapy treatment in women with female pattern hair loss at a tertiary care centre.

An observational study to evaluate the efficacy of bicalutamide mesotherapy treatment in women with female pattern hair loss at a tertiary care centre - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/07/113261
Enrollment
30
Registered
2026-07-02
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L648- Other androgenic alopecia

Interventions

Intervention1: Bicalutamide mesotherapy: 1ml of bicalutamide injected intradermally in the scalp 2 weeks apart with a total of four sessions Control Intervention1: Nil: Nil

Sponsors

Department of Dermatology,Sion Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: females with FPHL grade II and above with completed family or using contraception 3 months during and beyond the treatment period

Exclusion criteria

Exclusion criteria: Patients not wiling to participate in the study or unable to give consent, Patients of child bearing age and not using contraception, Pregnancy, Lactation

Design outcomes

Primary

MeasureTime frame
Evaluate the efficacy of bicalutamide mesotherapy using global photography and trichoscopic parametersTimepoint: At Baseline and 12 weeks—

Secondary

MeasureTime frame
Evalutate the reduction in seborrhea using patient satisfactionTimepoint: Baseline and 3 months—

Countries

India

Contacts

Public ContactDr Rachita Dhurat

LTMMC and GH,Sion,Mumbai

rachitadhurat@yahoo.co.in9833394951

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026